Comparative analysis of cyclin D1 and oestrogen receptor (α and β) levels in human leiomyoma and adjacent myometrium

Kálmán A. Kovács, Angéla Oszter, Péter M. Göcze, József L. Környei, I. Szabó

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The aim of these experiments was to investigate the expression of cyclin D1 and of oestradiol receptors as well as the level of [3H]oestradiol binding in leiomyoma and adjacent myometrium from human uteri at different menstrual phases and at an early stage of menopause. [3H]oestradiol binding was determined by saturation analysis, while the oestradiol receptor (ER) α and β and cyclin D1 levels were determined by Western blot analysis of 16 samples of human leiomyomas and corresponding myometria at different hormonal stages. In leiomyomas during all phases of the menstrual cycle, ERα expression, high affinity oestradiol binding and cyclin D1 expression were all elevated in comparison with adjacent myometrium. ERβ expression and low affinity oestradiol binding were enhanced in leiomyomas only during the proliferative phase. During menopause, ERβ expression and low affinity binding were enhanced in leiomyomas, while the ERα expression was not significantly enhanced and cyclin D1 levels were similar to that in myometrium. Only the oestradiol binding exhibited any menstrual cycle-related changes. Our data suggest the involvement of cyclin D1 in the growth of leiomyomas during the menstrual cycle. In menopause, there appears to be a switch from ERα to ERβ expression in leiomyomas, and the induction of cyclin D1 is decreased. The regression of tumour may ensue from these changes at menopause.

Original languageEnglish
Pages (from-to)1085-1091
Number of pages7
JournalMolecular Human Reproduction
Volume7
Issue number11
Publication statusPublished - 2001

Fingerprint

Myometrium
Cyclin D1
Leiomyoma
Estrogen Receptors
Estradiol
Menopause
Menstrual Cycle
Estradiol Receptors
Uterus
Western Blotting
Growth
Neoplasms

Keywords

  • Cyclin D1
  • Human leiomyoma
  • Menopause
  • Menstrual cycle
  • Oestrogen receptors

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Genetics
  • Developmental Biology
  • Embryology
  • Cell Biology

Cite this

Comparative analysis of cyclin D1 and oestrogen receptor (α and β) levels in human leiomyoma and adjacent myometrium. / Kovács, Kálmán A.; Oszter, Angéla; Göcze, Péter M.; Környei, József L.; Szabó, I.

In: Molecular Human Reproduction, Vol. 7, No. 11, 2001, p. 1085-1091.

Research output: Contribution to journalArticle

Kovács, Kálmán A. ; Oszter, Angéla ; Göcze, Péter M. ; Környei, József L. ; Szabó, I. / Comparative analysis of cyclin D1 and oestrogen receptor (α and β) levels in human leiomyoma and adjacent myometrium. In: Molecular Human Reproduction. 2001 ; Vol. 7, No. 11. pp. 1085-1091.
@article{42ceb0b2bc324110a24b922075e9e700,
title = "Comparative analysis of cyclin D1 and oestrogen receptor (α and β) levels in human leiomyoma and adjacent myometrium",
abstract = "The aim of these experiments was to investigate the expression of cyclin D1 and of oestradiol receptors as well as the level of [3H]oestradiol binding in leiomyoma and adjacent myometrium from human uteri at different menstrual phases and at an early stage of menopause. [3H]oestradiol binding was determined by saturation analysis, while the oestradiol receptor (ER) α and β and cyclin D1 levels were determined by Western blot analysis of 16 samples of human leiomyomas and corresponding myometria at different hormonal stages. In leiomyomas during all phases of the menstrual cycle, ERα expression, high affinity oestradiol binding and cyclin D1 expression were all elevated in comparison with adjacent myometrium. ERβ expression and low affinity oestradiol binding were enhanced in leiomyomas only during the proliferative phase. During menopause, ERβ expression and low affinity binding were enhanced in leiomyomas, while the ERα expression was not significantly enhanced and cyclin D1 levels were similar to that in myometrium. Only the oestradiol binding exhibited any menstrual cycle-related changes. Our data suggest the involvement of cyclin D1 in the growth of leiomyomas during the menstrual cycle. In menopause, there appears to be a switch from ERα to ERβ expression in leiomyomas, and the induction of cyclin D1 is decreased. The regression of tumour may ensue from these changes at menopause.",
keywords = "Cyclin D1, Human leiomyoma, Menopause, Menstrual cycle, Oestrogen receptors",
author = "Kov{\'a}cs, {K{\'a}lm{\'a}n A.} and Ang{\'e}la Oszter and G{\"o}cze, {P{\'e}ter M.} and K{\"o}rnyei, {J{\'o}zsef L.} and I. Szab{\'o}",
year = "2001",
language = "English",
volume = "7",
pages = "1085--1091",
journal = "Molecular Human Reproduction",
issn = "1360-9947",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Comparative analysis of cyclin D1 and oestrogen receptor (α and β) levels in human leiomyoma and adjacent myometrium

AU - Kovács, Kálmán A.

AU - Oszter, Angéla

AU - Göcze, Péter M.

AU - Környei, József L.

AU - Szabó, I.

PY - 2001

Y1 - 2001

N2 - The aim of these experiments was to investigate the expression of cyclin D1 and of oestradiol receptors as well as the level of [3H]oestradiol binding in leiomyoma and adjacent myometrium from human uteri at different menstrual phases and at an early stage of menopause. [3H]oestradiol binding was determined by saturation analysis, while the oestradiol receptor (ER) α and β and cyclin D1 levels were determined by Western blot analysis of 16 samples of human leiomyomas and corresponding myometria at different hormonal stages. In leiomyomas during all phases of the menstrual cycle, ERα expression, high affinity oestradiol binding and cyclin D1 expression were all elevated in comparison with adjacent myometrium. ERβ expression and low affinity oestradiol binding were enhanced in leiomyomas only during the proliferative phase. During menopause, ERβ expression and low affinity binding were enhanced in leiomyomas, while the ERα expression was not significantly enhanced and cyclin D1 levels were similar to that in myometrium. Only the oestradiol binding exhibited any menstrual cycle-related changes. Our data suggest the involvement of cyclin D1 in the growth of leiomyomas during the menstrual cycle. In menopause, there appears to be a switch from ERα to ERβ expression in leiomyomas, and the induction of cyclin D1 is decreased. The regression of tumour may ensue from these changes at menopause.

AB - The aim of these experiments was to investigate the expression of cyclin D1 and of oestradiol receptors as well as the level of [3H]oestradiol binding in leiomyoma and adjacent myometrium from human uteri at different menstrual phases and at an early stage of menopause. [3H]oestradiol binding was determined by saturation analysis, while the oestradiol receptor (ER) α and β and cyclin D1 levels were determined by Western blot analysis of 16 samples of human leiomyomas and corresponding myometria at different hormonal stages. In leiomyomas during all phases of the menstrual cycle, ERα expression, high affinity oestradiol binding and cyclin D1 expression were all elevated in comparison with adjacent myometrium. ERβ expression and low affinity oestradiol binding were enhanced in leiomyomas only during the proliferative phase. During menopause, ERβ expression and low affinity binding were enhanced in leiomyomas, while the ERα expression was not significantly enhanced and cyclin D1 levels were similar to that in myometrium. Only the oestradiol binding exhibited any menstrual cycle-related changes. Our data suggest the involvement of cyclin D1 in the growth of leiomyomas during the menstrual cycle. In menopause, there appears to be a switch from ERα to ERβ expression in leiomyomas, and the induction of cyclin D1 is decreased. The regression of tumour may ensue from these changes at menopause.

KW - Cyclin D1

KW - Human leiomyoma

KW - Menopause

KW - Menstrual cycle

KW - Oestrogen receptors

UR - http://www.scopus.com/inward/record.url?scp=0034759143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034759143&partnerID=8YFLogxK

M3 - Article

C2 - 11675476

AN - SCOPUS:0034759143

VL - 7

SP - 1085

EP - 1091

JO - Molecular Human Reproduction

JF - Molecular Human Reproduction

SN - 1360-9947

IS - 11

ER -